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Abstract
Objective: Relatives of colorectal cancer (CRC) patients are at increased risk for the disease, yet
screening rates still remain low. Guided by the Extended Parallel Process Model (EPPM) we
examined the impact of a personalized, remote risk communication intervention on behavioral
intention and colonoscopy-uptake in relatives of CRC patients, assessing the original additive
model and an alternative model in which each theoretical construct contributes uniquely.
Methods: We collected intention-to-screen and medical-record-verified colonoscopy information
on 218 individuals who received the personalized intervention.

Author Manuscript

Results: Structural equation modeling showed poor main model fit (RMSEA=0.109;
SRMR=0.134; CFI=0.797; AIC=11601; BIC=11884). However, the alternative model
(RMSEA=0.070; SRMR=0.105; CFI=0.918; AIC=11186; BIC=11498) showed good fit. Cancer
susceptibility (B =0.319, p <.001) and colonoscopy self-efficacy (B=0.364, p<0.001) perceptions
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predicted intention-to-screen which was significantly associated with colonoscopy uptake
(B=0.539, p<0.001).
Conclusions: Our findings provide support of the utility of EPPM for designing effective
interventions to motivate CRC screening in persons at increased risk when individual elements of
the model are considered.
Keywords
cancer; oncology; colorectal cancer; EPPM; efficacy; threat
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Average lifetime risk for developing colorectal cancer (CRC) is approximately 5%; having a
first-degree relative (FDR) with CRC increases risk two to eight-fold [1, 2]. Colonoscopy
has the potential to reduce both CRC incidence and mortality through early detection and
removal of precancerous polyps. The American Cancer Society and the National
Comprehensive Cancer Network recommend individuals with an intermediate risk of
familial CRC (i.e., CRC diagnosis in a FDR < age 60 or two or more FDR or second-degree
relatives (SDR) with CRC) begin CRC screening at age 40, or 10 years earlier than the
youngest age at diagnosis in the family, whichever comes first [3, 4] and to repeat screening
every 3-5 years. Because colonoscopy is effective at cancer prevention through early
detection and removal of polyps, it is the standard of care for most individuals considered to
be at increased familial risk[5].

Author Manuscript

CRC incidence and mortality rates have been declining in the United States since the
mid-1980s, largely attributed to the increase in detection and removal of precancerous
polyps through colonoscopy [6], yet screening rates among relatives of CRC patients remain
low [7]. Less than half of individuals at increased familial risk are up-to-date with
colonoscopy [8]. Low adherence to screening recommendations may be related to lack of a
clear understanding of familial risk and current screening recommendations [9]. The low
participation rates of intermediate-risk individuals underscore the importance of developing
effective strategies for increasing adherence to CRC screening.
Effective risk communication depends not only on presenting general risk factors and
preventive information but also on factors unique to the individual. Acceptance of a risk
message depends on an individual’s knowledge, values and beliefs.[10]. Personalized
interventions in which the message is based on an individual’s beliefs about CRC, personal
risk factors, and knowledge of the effectiveness of CRC screening [11] may be viewed as
more salient and lead to the desired behavior.

Author Manuscript

Theory-based interventions addressing multiple determinants of behavior have the highest
likelihood of promoting healthy behaviors [12]. One such theory is the Extended Parallel
Process Model (EPPM) which incorporates affective processes (i.e., fear) in risk
communication [13]. The EPPM focuses on channeling fear in a protective direction rather
than a maladaptive direction. The model is based on the idea that when individuals fear a
threat, they will be motivated to take action to reduce the unpleasant state. Fear can then be
reduced by adaptive actions to control the danger or by maladaptive actions to control the
fear. The model posits that when an individual is presented with a fear-arousing message two
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cognitive appraisal processes will be initiated: (1) threat appraisal and (2) efficacy appraisal.
In the first stage, the individual considers two aspects of the perceived threat: severity and
susceptibility. Severity appraisals involve determining the degree of harm expected from the
threat (e.g., “CRC can kill me.”) while susceptibility appraisals involve determining how
likely the threat could affect the individual (e.g. “I have a family history of CRC so I can get
this disease.”). If the perceived threat is determined to be low, the individual is unlikely to
process the message further. However, if the perceived threat is high the individual will enter
the efficacy appraisal stage to evaluate response efficacy and self-efficacy. In response
efficacy the individual assesses how effective the recommended behavior will be in averting
the threat. (“Colonoscopies can identify cancer early and save my life.”). In self-efficacy the
individual assesses their ability to perform the recommended behavior to avert the threat (“I
am capable of getting a colonoscopy.”). . When both threat and efficacy appraisals are high,
the individual will enter a cognitive process to control the danger and will engage in adaptive
behavior (e.g., getting a colonoscopy). If threat appraisals are high but efficacy is low, the
individual will enter a cognitive process to control the fear rather than the danger. This
process is likely to lead to maladaptive responses such as defensive avoidance (e.g., “I’m not
going to think about that!”)

Study Aims
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Prior cancer-related studies have examined the EPPM in relation to smoking cessation [14],
and early detection behaviors such as testicular self-exam [15] , mammography [16], skin
cancer screening and sun protective behaviors [17] but little is known about how the EPPM
influences CRC screening intentions and behavior. To address this gap, we explored the
validity of the EPPM on predicting message acceptance in the context of a personalized risk
communication intervention effects on intention to screen and on colonoscopy utilization.
We examined whether perceptions of CRC threat and efficacy were associated with greater
message acceptance, and whether perceived CRC threat and efficacy were associated with
fear and maladaptive responses at controlling the fear, namely defensive avoidance.

Author Manuscript

In the event the data did not fit the main additive model, we planned to examine an
alternative model. In Witte’s original EPPM model, perceptions of threat are determined by
combining susceptibility scores with severity scores and perceptions of efficacy are
determined by combining response efficacy scores with self-efficacy scores [18]. However,
with regard to CRC threat we postulated there would be little variance in the perceived
severity scores as prior research on cancer screening behavior has found perceptions of
cancer severity to be universally high [19]. Likewise, we posited that self-efficacy and
response efficacy contribute uniquely to the model. While an individual may have high
levels of perceived response efficacy (“Colonoscopy can save my life.”), low self-efficacy
perceptions (“I am unable to get a colonoscopy.”) may substantially influence overall
perceived efficacy scores. Prior studies examining utilization of CRC screening have
indicated that individuals without insurance and in lower socioeconomic strata were less
likely to have ever screened [20]. These barriers are likely to have influence on efficacy
perceptions and screening behavior. Therefore, if the additive model indicated poor fit we
planned to examine the individual EPPM constructs of perceived severity, susceptibility,
response efficacy and self-efficacy as distinct factors contributing to the model (alternative
Psychooncology. Author manuscript; available in PMC 2020 April 16.
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model). In the case of poor additive model fit we hypothesized that our alternative model
would show perceived susceptibility and perceived self-efficacy to be associated with greater
message acceptance.

Method
Participants and Intervention

Author Manuscript
Author Manuscript

This study used data from the Family Colorectal Cancer Awareness and Risk Education
Project (Family CARE). The Family CARE Project tested the efficacy of a theoreticallybased personalized CRC risk assessment and behavior change intervention (TeleCARE)
based on the EPPM. All participants had at least one close relative with CRC and met the
criteria for enhanced screening with colonoscopy [3, 4]. The intervention is described in
detail elsewhere [21-24]. Briefly, the intervention consisted of mailed tailored print materials
and a cancer risk assessment and counseling telephone call by a genetic counselor.
Participants were recruited through state cancer registries in California, Colorado, Idaho,
New Mexico, and Utah; from Cancer Genetics Network’s population-based registries in
Colorado, New Mexico and Utah; and from two hospital based registries covering
approximately 85% of cancer care in Utah. Eligibility requirements included participants be
age 30-74 years; be at intermediate risk for CRC; were not members of families with
hereditary CRC and had not had a colonoscopy in the prior 5 years. Participants were
initially contacted by mail or telephone and after providing informed consent, completed a
mail or telephone baseline survey [23, 24]. Eligible participants (n=481) completed the
baseline survey and were randomized to one of two arms. Investigators and telephone
interviewers were blinded to participant condition. The intervention arm consisted of a
tailored telephone-based CRC risk counseling session with a cancer risk specialist (i.e.,
genetic counselor) as well as follow up letters and reminder postcards. Telephone sessions
were tailored to the participants’ perceptions of CRC risk and severity, self-efficacy
regarding obtaining colonoscopy and beliefs about colonoscopy effectiveness. Sessions
incorporated risk communication and behavior change approaches based on raising
perceptions of threat of familial CRC, arousing fear, enhancing beliefs about colonoscopy
benefits and increasing self-efficacy and motivation to undergo colonoscopy. The
comparison group received a mailed generic educational brochure only. Two-hundred
eighteen eligible participants were randomly assigned to the TeleCARE arm and completed
the intervention and were included in this study’s intent-to-treat analysis. Of these, 188
(86%) returned the one-month follow-up survey and were included in the per protocol
analysis. Because the TeleCARE intervention was explicitly guided by the EPPM while the
control arm was not, this analysis included only those in the TeleCARE arm.

Author Manuscript

Within one month of the baseline survey, one of five certified cancer genetic counselors
conducted a 30-45 minute telephone session with each participant, individualizing the
counseling session according to participant’s perceptions of CRC threat, screening efficacy,
and perceived barriers. The session included a “fear-appeal” that informed the individual
about their increased risk for CRC, and population risks of dying of CRC and mortality.
Counselors discussed colonoscopy as a strategy for reducing the risk of developing CRC and
detecting it early. Counselors also recommended or reinforced the benefits of getting a
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colonoscopy because of their familial risk. Thirty days following the intervention,
participants completed a mailed or telephone follow-up survey that assessed threat and
efficacy perceptions, intention to get a colonoscopy and actual colonoscopy utilization.
Reported colonoscopy was medically verified. The trial’s primary outcome was medically
verified colonoscopy by the 9 month follow-up.
Measures
Perceived threat and perceived efficacy.—EPPM threat and efficacy constructs were
assessed using an adapted version (i.e., adapted to refer to colorectal cancer and/or
colonoscopy specifically) of the16-item Risk Behavior Diagnosis Scale (RBDS) [25]. Each
construct included four items and individuals indicated agreement with statements using a 5point Likert-type scale ranging from 1 (strongly agree) to 5 (strongly disagree) (see Table 1
for Cronbach’s alpha on these and all subsequent constructs).

Author Manuscript

Fear.—CRC fear was assessed with an adapted (i.e., adapted to refer to colorectal and/or
colonoscopy cancer specifically) six-item scale from the Negative Affect in Risk subscale of
the Cancer Risk Beliefs Scale [26]. Participants indicated agreement using a 4-point Likerttype scale ranging from 1 (strongly agree) to 4 (strongly disagree).
Defensive avoidance.—To assess if participants avoided thinking about the intervention
information as an effort to control fear we utilized an adapted (i.e., adapted to refer to
colorectal cancer and/or colonoscopy specifically) [13] 3-item scale utilizing a 7-point
Likert-type scale where 1 = “I didn’t want to think about it” and 7 = “I wanted to think about
it.”

Author Manuscript

Message acceptance.—Intention to be screened for CRC was assessed with a single
item, “Do you intend to have a colonoscopy in the next 6 months?” on a 7-point Likert-type
scale ranging from 1 (definitely will not have) to 7 (definitely will have). CRC screening
behavior was assessed at each follow up. Colonoscopy utilization was verified by medical
records within 9 months post-intervention.
Analysis

Author Manuscript

Structural equation modeling (SEM) was used to assess the data fit to the proposed
theoretical model that was developed a priori according to the EPPM theory. Before
examining the additive and the alternative models, we tested the adequacy of each
measurement model to operationalize the latent variables and examine goodness of fit. To
assess the measurement model fit, we considered Root Mean Square Error of Approximation
(RMSEA)<.08, Comparative Fit Index (CFI)>.90 and Standardized Root Mean Residual
(SRMR)<.08 as good fit to the models [27-29].
A full SEM analysis was then conducted to specify a priori hypothesized relationships
among the latent and/or observed variables in the model.. We conducted intent-to-treat
analyses of the hypothesized models, as well as per protocol analyses to examine whether
there is any major discrepancy between the per protocol and intent-to-treat results. Full
information maximum likelihood (FIML) estimation was used to impute missing values. In
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addition, a sensitivity analysis with and without imputation for missing data was conducted.
Three sets of missing data imputation (FIML, multiple imputations (MI) with 5 replications,
MI with 10 replications) were performed. Model fit was assessed by RMSEA, SRMR, and
CFI. We compared the models based on the model fit indices, Akaike Information Criterion
(AIC) and Bayesian Information Criterion (BIC), with lower AIC and BIC indicating
preferred model.

Results
Participant sociodemographics are presented in Table 2. Logistic regression analysis of
responders versus non-responders to the 1-month intention and behavior items revealed no
difference between the groups on baseline demographics or EPPM variables.

Author Manuscript

Confirmatory factor analyses showed that our four self-efficacy items had poor fit (RMSEA
= 0.452, CFI= 0.786, SRMR= 0.102). In order to achieve good-fitting measurement models,
the latent construct was re-specified. After excluding one self-efficacy item, (“I can get a
colonoscopy to prevent the onset of colorectal cancer”) the self-efficacy construct showed
excellent fit (RMSEA = 0.00, CFI= 1.00, SRMR= 0.00) [30, 31]. Results of the main
additive and alternative measurement models and confirmatory factor fit indices are reported
in Tables 1, 2 and 3 of the Appendix.
Main additive model results.
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The overall fit statistics indicated that the measurement model for the four latent constructs
(threat, efficacy, fear, defensive avoidance) did not fit the data (RMSEA=0.113;
SRMR=0.109; CFI=0.811) (see Table 1 of the Appendix). The full SEM analysis of the
hypothesized main additive model did not support the model’s fit (RMSEA=0.109;
SRMR=0.134; CFI=0.797; AIC=11601; BIC=11884). (see Figure 1). Even though the fit
indices did not support the main additive model, we still reported the results as this model is
the original theoretical model and a comparison of the fit with the alternative model was the
overarching goal of this study.
Alternative model results.

Author Manuscript

The overall fit statistics indicated the alternative measurement model for the six latent
constructs provided adequate fit to the data (RMSEA=0.068; SRMR=0.063; CFI=0.933)
(see Table 2 of the Appendix). Intercorrelations among the six constructs for the alternative
models are presented in Table 4 of the Appendix. We compared the main additive model
versus the alternative model based on RMSEA, SRMR, CFI, AIC and BIC indices, with
lower RMSEA, lower SRMR, lower AIC, lower BIC and higher CFI indicating a better
model. Results from the FIML intent-to-treat analyses indicated the alternative model is a
better fit than the main model in all areas (RMSEA=0.070; SRMR=0.105; CFI=0.918;
AIC=11186; BIC=11498). As shown in Figure 2, we found perceived susceptibility to be
associated with intention to screen (B =0.319, p <.001) but no association between perceived
severity (B=0.061, p=0.444) and intention. Perceived self-efficacy (B=0.364, p<0.001) was
associated with intention but perceived response efficacy was not (B=−0.181, p=0.113).
Neither perceived susceptibility (B=.132, p=0.158) nor perceived self-efficacy (B=−0.181,
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p=0.113) were associated with fear; however perceived severity (B=0.177, p=0.034) and
perceived response efficacy (B=0.242 p=0.043) were both associated with fear. When we
examined fear processes, we found fear to be associated with lower levels of defensive
motivation (B=−0.343, p<0.001). Importantly, intention to screen was associated with
colonoscopy behavior (B=0.539, p<0.001). The results obtained from the per-protocol
analyses (See Figures 1 and 2 in Appendix) were essentially identical to the intent-to-treat
analyses reported above. Additionally, the results with and without imputation for missing
data were concordant. (See Figures 3, 4, 5, 6, 7 and 8 in Appendix)

Discussion

Author Manuscript
Author Manuscript

Risk communication involves raising awareness of increased cancer risk and creating a sense
of efficacy. The EPPM contains both components and has been effectively used across a
variety of topics[32], but has not previously been examined in the context of CRC screening
intentions and behavior. Our study examined the full EPPM in which an additive
relationship exists between perceived severity and susceptibility (i.e., threat) and between
perceived response and self-efficacy (i.e., efficacy) to determine the model’s predictive
validity regarding model effectiveness on CRC screening intentions and behavior. Our
findings did not support the main additive EPPM model. Another aim, upon main model
poor fit, was to examine an alternative model in which perceived susceptibility, severity, selfefficacy and response efficacy each contribute individually to the model. Consistent with our
hypothesis perceived susceptibility was significantly associated with intention to screen
while perceptions of CRC severity were not. Additionally, perceived self-efficacy but not
perceived response efficacy was significantly associated with intention to screen. According
to the tenets of the EPPM, when one is exposed to a fear appeal message, an appraisal of the
message’s threat is first preformed and then an appraisal of the individual’s ability to prevent
the threat. However, perceptions of cancer severity may fundamentally differ from other
types of fear appeal severity messages. Cancer has been considered the “dread disease”[19],
impacting lifestyle, incurring high costs and causing significant and permanent morbidity.
Furthermore, cancer is often viewed as so frightening that individuals may refrain from
obtaining cancer screening tests due to their fear of being diagnosed with cancer [33] and the
belief that death is inevitable when cancer is present [34]. Consistent with this view our data
indicate that most participants viewed CRC as serious and severe with little variability in
perceived severity scores. Such high severity scores create a ceiling effect that may affect the
threat component in the main additive model. Thus, fear-arousing cancer-related messages,
specifically those focused on CRC, should focus on increasing levels of personal
susceptibility, prevention and on early detection strategies.

Author Manuscript

In the main additive model, perceived self- and response efficacy are combined to create an
efficacy value. According to the EPPM, self-efficacy may be viewed as the degree to which
the individual perceives he/she can perform the recommended response to avert the threat. In
the case of CRC and for the purposes of our study self-efficacy is the degree to which the
individual perceives he/she is capable of obtaining a colonoscopy and response efficacy is
the degree to which the individual believes that colonoscopy can early-detect and prevent
CRC. In fear-arousing communications aimed to increase health-promoting lifestyle choices,
self-efficacy is often associated with the self-control, self-regulation and self-motivation
Psychooncology. Author manuscript; available in PMC 2020 April 16.
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needed to perform the behavior. However, many of these health-promoting lifestyle
behaviors need to be performed on a regular basis, while colonoscopy screening need only
be performed every few years for most people with a family history of cancer and in this
case would be considered as a single-event decision. Additionally, while colonoscopy selfefficacy would include the self-motivation to actively pursue a colonoscopy recommendation
from a provider and to follow up with that recommendation, screening for CRC also
involves securing transportation from a social network member, having insurance coverage
or the ability to pay for a rather costly procedure. Prior research has consistently shown an
association between lack of health insurance and non-adherence to cancer screening
guidelines [35]. Accordingly while one may strongly agree that colonoscopy can save lives,
without the ability to pay either the cost of the colonoscopy or the copay, belief in the
effectiveness of colonoscopy would not likely predict intention to obtain colonoscopy nor
predict colonoscopy uptake. Messages to increase efficacy may need to include information
on transportation options and ways to obtain colonoscopy if one’s insurance does not cover
the cost.
Importantly, we also examined colonoscopy behavior within nine months following the
intervention and, as hypothesized, our results indicated motivation to screen was
significantly associated with colonoscopy uptake. This is an important aspect to examine, as
people with positive intentions often fail to actually perform the behavior [36].

Author Manuscript

Of particular interest is our finding that fear was negatively associated with maladaptive
responses, suggesting participants did not avoid the message despite high fear. It may be that
a cancer message cannot be dismissed easily. One often need not look beyond one’s own
neighborhood to see examples of the significant and harmful impact cancer can have on
families, finances and lives. It would likely be difficult to dismiss cancer fear messages as
“unimportant” or “not worth thinking about”. Our participants all had a family member with
CRC diagnosis and may well have seen these impacts first hand. While some fear messages
might be viewed as less threatening than cancer and thus may be easier to derogate or avoid,
cancer fear cannot be easily dismissed. Additionally, effective communication depends on
whether the individual views the communication source as credible [10]. Our participants
may have viewed the risk counselors as credible and thus did not discredit their message.
Importantly, individuals seemed to believe the relevance of the message regarding CRC
despite increased levels of fear.

Author Manuscript

The EPPM-based intervention [22] was effective in promoting CRC screening behavior and
an examination of pre-to-post intervention changes [23] indicated the intervention increased
CRC knowledge, perceptions of susceptibility, response efficacy, self-efficacy and reduced
decisional uncertainty from baseline to follow-up. In this study, we aimed to assess the
underlying theoretical model to determine whether the original EPPM additive model versus
an alternative model was a better fit. Thus, our findings provide a unique contribution to the
literature regarding the use of the EPPM in promoting adherence to CRC screening
guidelines in those at increased familial risk. Specifically, our findings suggest that the
EPPM alternative model in which each component of the EPPM contributes individually is a
better fit for motivating CRC screening intentions and CRC screening behavior. This is an
important contribution to the literature as few studies have tested theoretical models with
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regard to an intervention’s effect on psychosocial pathways and actual cancer screening
behavior [37] and there remains no clear agreement on which model best predicts cancer
screening behaviors. Empirical examination of theories to better understand causal pathways
that link constructs to cancer screening behavior is an important first step. Noteworthy, in
our study we measured not only participants’ intention to screen as an indicator of message
acceptance, but their actual behavior as well.

Author Manuscript

While our study has provided an important examination of how the EPPM framework may
aid in interventions to motivate CRC screening intentions and behavior, our study has
limitations. Specifically, the majority of our population was non-Hispanic white. Most of our
population reported having health insurance, however, the TeleCARE intervention was
effective in motivating colonoscopy within 15 months of intervention in both those who did
and did not report cost barriers, although it was more effective in those who did not cite cost
as a barrier [38]. While no ethnic/racial or insurance differences were observed, differences
may emerge with a more racially diverse or uninsured population. Thus, our results cannot
be generalized to other socioeconomic groups. Additional work are needed to assess the
feasibility of the EPPM framework to motivate more socioeconomically disadvantaged and
uninsured/underinsured populations. Finally, our surveys were remotely administered. This
led to a higher rate of missing responses than would have been achieved with in-person
surveys.
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An important extension to this study would include determining if factors beyond the control
of the participant function to inhibit colonoscopy behavior. Qualitative studies to identify
such factors would be useful. Additionally, we did not explore the pathways between fear
and intention-to-screen and actual screening behavior for two reasons: this particular
pathway was not specified in Witte’s original model and our sample size limited the number
of pathways we could include in the model. However, it might be informative to examine
this pathway in future. Nonetheless, our finding support key theoretical tenets of the EPPM
and can be used to guide the development and implementation of effective interventions to
promote guideline-concordant cancer screening.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

Main model - Standardized effects with p values in parentheses. RMSEA=0.109;
CFI=0.797; SRMR=0.134.
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Figure 2.

Alternative model - Standardized effects with p values in parentheses. RMSEA=0.070;
CFI=0.918; TLI=0.906; SRMR=0.105.
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Author Manuscript

Cronbach’s alpha for latent variables

Author Manuscript

Latent Variables
Main model

Cronbach’s Alpha

THREAT

0.878

EFFICACY

0.880

FEAR

0.941

Defensive avoidance

0.790

Latent Variables
Alternative model

Cronbach’s Alpha

Self-efficacy

0.817

Response efficacy

0.881

Perceived susceptibility

0.849

Perceived severity

0.952

Fear

0.941

Defensive avoidance

0.790
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Table 2

Author Manuscript

Demographic characteristics (N=188)
Variable

n (%)

Age
<40 years

12 (6.4)

40-49

83 (44.1)

50-59

60 (31.9)

60-69

28 (14.9)

70+

5 (2.7)

Sex
Male

65 (34.6)

Female

123 (65.4)

Race/Ethnicity

Author Manuscript

Race Unknown, not Hispanic

1 (0.5)

Any Race, Hispanic

7 (3.7)

White, not Hispanic

175 (93.1)

Black, not Hispanic

2 (1.1)

Other

3 (0.5)

Education
<High school

5 (2.7)

High School/GED

35 (18.6)

Some college/college grad

123 (65.5)

Postgrad

25 (13.3)

Income

Author Manuscript

Refused

20 (10.6)

Less than 15,000

21 (11.2)

15,000 – 29,999

20 (10.6)

30,000 – 49,999

35 (18.6)

50,000 – 69,999

30 (16.0)

70,000 or more

62 (33.0)
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